Dr. Moler is Professor of Pediatrics and Communicable Diseases in the Division of Pediatric Critical Care Medicine. He received his MD degree from the University of Michigan Medical School and then completed both his residency in Pediatrics and fellowship training in Pediatric Critical Care Medicine at the University of Michigan. Upon completing his fellowship training, he remained on faculty at the University of Michigan and completed a M.S. degree in Clinical Research Design and Statistical Analysis from the University of Michigan School of Public Health. His research interests focus on multicenter clinical research studies related to the field of pediatric emergency and critical care medicine. Areas of current and past expertise include cardiac arrest, therapeutic hypothermia, severe cardiac and respiratory failure requiring rescue therapies, ECMO, inhaled and intravenous beta 2 agonists, asthma, RSV and severity of illness outcome modeling. He has been a member of two federally funded pediatric clinical research networks: Pediatric Emergency Care Applied Research Network (PECARN) and Collaborative Pediatric Critical Care Research Network (CPCCRN). Dr. Moler’s recent research support is with NHLBI, where he is the lead PI of two international multicenter clinical trials (THAPCA) conducted at 46 sites in the US, Canada and UK. The THAPCA trials investigated the efficacy of therapeutic hypothermia after pediatric cardiac arrest in the in-hospital (NCT00880087) and out-of-hospital (NCT00878644) settings. He is currently Co-Medical Director of the Children’s Clinical Trial Support Unit (CCTSU), which provides infrastructure support for conduct of clinical trials in pediatric patients at Michigan Medicine.
